EE03906B1 - Farmatseutilised preparaadid östrogeenipuudulikkuse selektiivseks korvamiseks kesknärvisüsteemis - Google Patents
Farmatseutilised preparaadid östrogeenipuudulikkuse selektiivseks korvamiseks kesknärvisüsteemisInfo
- Publication number
- EE03906B1 EE03906B1 EEP200000477A EEP200000477A EE03906B1 EE 03906 B1 EE03906 B1 EE 03906B1 EE P200000477 A EEP200000477 A EE P200000477A EE P200000477 A EEP200000477 A EE P200000477A EE 03906 B1 EE03906 B1 EE 03906B1
- Authority
- EE
- Estonia
- Prior art keywords
- central nervous
- nervous system
- transcription
- estradiol
- oestrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19807264 | 1998-02-20 | ||
| DE1998121831 DE19821831A1 (de) | 1998-05-15 | 1998-05-15 | Pharmazeutische Präparate zur gezielten Substitution des Estrogenmangels im Zentralnervensystem |
| PCT/DE1999/000353 WO1999042108A1 (de) | 1998-02-20 | 1999-02-10 | Pharmazeutische präparate zur gezielten substitution des estrogenmangels im zentralnervensystem |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200000477A EE200000477A (et) | 2001-12-17 |
| EE03906B1 true EE03906B1 (et) | 2002-12-16 |
Family
ID=26044035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000477A EE03906B1 (et) | 1998-02-20 | 1999-02-10 | Farmatseutilised preparaadid östrogeenipuudulikkuse selektiivseks korvamiseks kesknärvisüsteemis |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1056460B1 (tr) |
| JP (1) | JP2002503694A (tr) |
| KR (1) | KR20010041107A (tr) |
| CN (1) | CN1291102A (tr) |
| AT (1) | ATE252388T1 (tr) |
| AU (1) | AU739071C (tr) |
| BG (1) | BG104689A (tr) |
| BR (1) | BR9909205A (tr) |
| CA (1) | CA2321498A1 (tr) |
| CZ (1) | CZ291764B6 (tr) |
| DE (1) | DE59907446D1 (tr) |
| EA (1) | EA002707B1 (tr) |
| EE (1) | EE03906B1 (tr) |
| HU (1) | HUP0100742A3 (tr) |
| ID (1) | ID27069A (tr) |
| IL (1) | IL137727A0 (tr) |
| IS (1) | IS5571A (tr) |
| NO (1) | NO20004153L (tr) |
| NZ (1) | NZ506049A (tr) |
| PL (1) | PL342313A1 (tr) |
| SK (1) | SK12152000A3 (tr) |
| TR (1) | TR200002400T2 (tr) |
| UA (1) | UA57830C2 (tr) |
| WO (1) | WO1999042108A1 (tr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2253318T3 (es) * | 2001-11-07 | 2006-06-01 | Schering Ag | Cribado in vitro de ligandos del receptor de estrogeno. |
| CN112189624A (zh) * | 2020-09-08 | 2021-01-08 | 山东第一医科大学(山东省医学科学院) | 一种利用受体基因沉默技术构建和鉴定女性ad模型的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897389A (en) * | 1984-10-29 | 1990-01-30 | Chaovanee Aroonsakul | Treating central nervous system diseases |
| US4791099A (en) * | 1984-10-29 | 1988-12-13 | Chaovanee Aroonsakul | Method of treatment for central nervous system diseases such as Alzheimer's's disease |
| DE4239946C2 (de) * | 1992-11-27 | 2001-09-13 | Jenapharm Gmbh | Estranderivate mit einer 14alpha,15alpha-Methylengruppe und Verfahren zu ihrer Herstellung |
| US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
| DE4338314C1 (de) * | 1993-11-10 | 1995-03-30 | Jenapharm Gmbh | Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen |
| DE4429397C2 (de) * | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE19524937A1 (de) * | 1995-07-08 | 1997-01-09 | Jenapharm Gmbh | Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann |
| WO1997003661A1 (en) * | 1995-07-24 | 1997-02-06 | University Of Florida Research Foundation, Incorporated | Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells |
-
1999
- 1999-02-10 AU AU29209/99A patent/AU739071C/en not_active Ceased
- 1999-02-10 ID IDW20001592A patent/ID27069A/id unknown
- 1999-02-10 EP EP99910118A patent/EP1056460B1/de not_active Expired - Lifetime
- 1999-02-10 WO PCT/DE1999/000353 patent/WO1999042108A1/de not_active Application Discontinuation
- 1999-02-10 CA CA002321498A patent/CA2321498A1/en not_active Abandoned
- 1999-02-10 CN CN99803170A patent/CN1291102A/zh active Pending
- 1999-02-10 SK SK1215-2000A patent/SK12152000A3/sk unknown
- 1999-02-10 KR KR1020007009148A patent/KR20010041107A/ko not_active Application Discontinuation
- 1999-02-10 TR TR2000/02400T patent/TR200002400T2/tr unknown
- 1999-02-10 NZ NZ506049A patent/NZ506049A/xx unknown
- 1999-02-10 JP JP2000532123A patent/JP2002503694A/ja not_active Abandoned
- 1999-02-10 CZ CZ20002938A patent/CZ291764B6/cs not_active IP Right Cessation
- 1999-02-10 HU HU0100742A patent/HUP0100742A3/hu unknown
- 1999-02-10 BR BR9909205-0A patent/BR9909205A/pt not_active IP Right Cessation
- 1999-02-10 EE EEP200000477A patent/EE03906B1/xx not_active IP Right Cessation
- 1999-02-10 DE DE59907446T patent/DE59907446D1/de not_active Expired - Fee Related
- 1999-02-10 AT AT99910118T patent/ATE252388T1/de not_active IP Right Cessation
- 1999-02-10 PL PL99342313A patent/PL342313A1/xx unknown
- 1999-02-10 EA EA200000858A patent/EA002707B1/ru not_active IP Right Cessation
- 1999-02-10 IL IL13772799A patent/IL137727A0/xx unknown
- 1999-10-02 UA UA2000095399A patent/UA57830C2/uk unknown
-
2000
- 2000-07-24 IS IS5571A patent/IS5571A/is unknown
- 2000-08-15 BG BG104689A patent/BG104689A/xx unknown
- 2000-08-18 NO NO20004153A patent/NO20004153L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL342313A1 (en) | 2001-06-04 |
| EP1056460B1 (de) | 2003-10-22 |
| CN1291102A (zh) | 2001-04-11 |
| EE200000477A (et) | 2001-12-17 |
| KR20010041107A (ko) | 2001-05-15 |
| AU2920999A (en) | 1999-09-06 |
| NZ506049A (en) | 2002-09-27 |
| CZ291764B6 (cs) | 2003-05-14 |
| JP2002503694A (ja) | 2002-02-05 |
| DE59907446D1 (de) | 2003-11-27 |
| BG104689A (en) | 2001-04-30 |
| EA002707B1 (ru) | 2002-08-29 |
| CZ20002938A3 (cs) | 2001-01-17 |
| WO1999042108A1 (de) | 1999-08-26 |
| TR200002400T2 (tr) | 2000-11-21 |
| EP1056460A1 (de) | 2000-12-06 |
| CA2321498A1 (en) | 1999-08-26 |
| ATE252388T1 (de) | 2003-11-15 |
| NO20004153L (no) | 2000-10-09 |
| HUP0100742A3 (en) | 2002-07-29 |
| UA57830C2 (uk) | 2003-07-15 |
| IL137727A0 (en) | 2001-10-31 |
| ID27069A (id) | 2001-02-22 |
| EA200000858A1 (ru) | 2001-04-23 |
| IS5571A (is) | 2000-07-24 |
| SK12152000A3 (sk) | 2001-02-12 |
| BR9909205A (pt) | 2000-11-14 |
| NO20004153D0 (no) | 2000-08-18 |
| HUP0100742A2 (hu) | 2001-09-28 |
| AU739071C (en) | 2002-04-11 |
| AU739071B2 (en) | 2001-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998027929A3 (de) | Therapeutische gestagene zur behandlung von premenstrual dysphoric disorder | |
| HUP0102483A2 (hu) | Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények | |
| WO1996019568A3 (en) | Stabilized ribozyme analogs | |
| TR199800648A1 (tr) | Iki veya daha fazla etken madde için ilaç verme sistemi. | |
| MXPA04001114A (es) | Derivados de aminoindazol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| BR9913374A (pt) | Compostos de gnrh não peptìdicos, composição farmacêutica e métodos para regular a secreção de gonadotropinas em mamìferos | |
| ATE235907T1 (de) | Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen | |
| ES2124905T3 (es) | Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad. | |
| ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
| EE200000477A (et) | Farmatseutilised preparaadid östrogeenipuudulikkuse selektiivseks korvamiseks kesknärvisüsteemis | |
| MY117307A (en) | New harmone medicaments and their use for correction of oestrogen deficiencies. | |
| GR3025872T3 (en) | Orally active derivatives of 1,3,5(10)-estratriene | |
| NO20005981L (no) | Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B | |
| WO2001085165A3 (de) | Kombination von liponsäure und c1-donoren zur behandlung von störungen des zentralen nervensystems | |
| ATE286739T1 (de) | Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme | |
| ATE319454T1 (de) | Sequentielle estrogen/progesteronantagonist- kombination für die hormonersatz-therapie | |
| CA2421302A1 (en) | 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds | |
| AU8624198A (en) | 11beta-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments. | |
| ES2113106T3 (es) | Esteres de 14alfa,15alfa-metilen-estradiol con efecto estrogeno administrables por via oral. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20040210 |